Trial Review

The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12619000209190
Ethics application status
Approved
Date submitted
7/02/2019
Date registered
13/02/2019
Date last updated
14/02/2022
Date data sharing statement initially provided
13/02/2019
Date results provided
14/02/2022
Type of registration
Prospectively registered

Titles & IDs
Public title
High-Protein vs Low-Carbohydrate Diets for Weight Loss
Scientific title
Higher-protein vs lower-carbohydrate energy-restricted diets: effects on eating behaviour, weight loss, and body composition in obese females.
Secondary ID [1] 297258 0
None
Universal Trial Number (UTN)
U1111-1215-2664
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Obesity 311332 0
Appetite control 311335 0
Condition category
Condition code
Diet and Nutrition 309972 309972 0 0
Obesity

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Participants will be randomised to follow either a High-Protein Normal-Carbohydrate (HPNC), High-Protein Low-Carbohydrate (HPLC), Normal-Protein Normal-Carbohydrate (NPNC) or Normal-Protein Low-Carbohydrate (NPLC) Low-Energy Diets (LED) for 8 weeks. The target macronutrient compositions are: (i) 50/40/10 en% of protein/carbohydrate/fat for HPNC; (ii) 50/28/22 en% of protein/carbohydrate/fat for HPLC; (iii) 35/40/25 en% of protein/carbohydrate/fat for NPNC; and (iv) 35/28/38 en% of protein/carbohydrate/fat for NPLC. Furthermore, the LED is aimed to provide approximately 40% of their daily energy requirements estimated using the Harris-Benedict Equation to generate an energy deficit for weight loss. The LED will be achieved through the consumption of 2 servings Cambridge Meal Replacements in combination with 2 home-prepared meals (breakfast and dinner) every day for a period of 8 weeks. This trial will provide the Cambridge Meal Replacements to the participants at no cost but the participants are required to buy the food ingredients to prepare their home-prepared meals while adhering to our meal plans.
The participants will attend a face-to-face group consultation at the Human Nutrition Unit, University of Auckland with a Registered Dietitian (RD) before the intervention is commenced and once every two weeks (Week 2, Week 4 and Week 6 after the intervention is commenced) to promote adherence to the diets.
The participants will also complete a 4-day food diary and a 24-hour urine collection at baseline, 4 weeks after the intervention is commenced and 8 weeks after the intervention is commenced to check for compliance.
Intervention code [1] 313512 0
Treatment: Other
Intervention code [2] 313619 0
Lifestyle
Comparator / control treatment
All 4 treatments (HPNC, HPLC, NPNC and NPLC) are active to induce weight loss. The treatments will be compared among each other to explore the differential effect of macronutrient composition on weight loss. The High-Protein Diets (HPLC and HPNC) will be compared against the Normal-Protein Diets (NPNC, NPLC), and the Low-Carbohydrate Diets (HPLC and NPLC) will be compared against the Normal-Carbohydrate Diets (HPNC and NPNC).
Control group
Active

Outcomes
Primary outcome [1] 318878 0
Change in body weight as assessed using a calibrated digital scale.
Timepoint [1] 318878 0
We are primarily interested in the difference between baseline and 8 weeks after intervention commenced. However, we also collect the body weight data at 4 weeks after the intervention commenced.
Secondary outcome [1] 366310 0
Objective markers of appetite as assessed using plasma concentration of appetite-related biomarkers (CCK, GLP-1, PYY)
Timepoint [1] 366310 0
At baseline and 8 weeks after intervention commenced.
Secondary outcome [2] 366311 0
Subjective feelings of appetite as assessed using Visual Analogue Scales (VAS)
Timepoint [2] 366311 0
At baseline and 8 weeks after intervention commenced.
Secondary outcome [3] 366312 0
Change in body composition (fat mass and fat-free mass) as assessed using a DEXA scan.
Timepoint [3] 366312 0
At baseline and 8 weeks after intervention commenced.

Eligibility
Key inclusion criteria
i. Females aged between 18 and 65 years.
ii. Obese (BMI 30 kg/m2 - 45kg/m2) with a maximum body weight of 130kg
iii. Otherwise healthy
Minimum age
18 Years
Maximum age
65 Years
Sex
Females
Can healthy volunteers participate?
No
Key exclusion criteria
i. Recent body weight loss/gain >5% within previous 3 months
ii. Currently taking part in an active diet program
iii. Current medications or other conditions known to affect body weight and appetite
iv. Previous bariatric surgery
v. Diagnosed with impaired liver or kidney function
vi. Significant current disease such as type 2 diabetes, cardiovascular disease, or cancer; or digestive disease including inflammatory bowel syndrome/disease (IBS/D), ulcerative colitis (UC), Crohn's disease
vii. Systolic blood pressure greater than or equal to 160 mmHg and/or diastolic blood pressure greater than or equal to 100mmHg
viii. Depression or any other anxiety disorder known to affect appetite
ix. Unable to consume food items included in the study, or hypersensitivities or allergies to these foods (based on Food Preference Questionnaire)
x. Smokers or ex-smokers who have given up smoking for less than 6 months
xi. Pregnant or breastfeeding women
xii. Unwilling/unable to comply with the study protocol

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Allocation not concealed
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Simple randomisation using a randomisation table created at https://www.randomizer.org/
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Parallel
Other design features
Phase
Not Applicable
Type of endpoint/s
Efficacy
Statistical methods / analysis
Power calculation is performed based on the data from a similar study conducted in The Netherlands (Soenen et al., 2012). The HP diet in this study resulted in a mean body weight reduction of 14kg over 12 weeks, with a standard deviation of 4kg. By applying these data, a sample size of 32 participants per diet arm is required to detect a difference of 2.8kg (20% of 14kg) in body weight between two diet groups (HP vs LC) with 80% power and a 5% level of significance. Assuming a dropout rate of 10%, we target recruitment of 35 participants per diet arm. Since there are 4 intervention diets (HPNC, HPLC, NPNC, and NPLC) in this study, a total of 140 participants will be recruited.
Differences between intervention arms will be tested using ANCOVA, whereas the differences of parameters between baseline and post-intervention within each intervention arm will be tested using paired T-test.

Recruitment
Recruitment status
Completed
Date of first participant enrolment
Anticipated
14/03/2019
Actual
18/03/2019
Date of last participant enrolment
Anticipated
30/09/2019
Actual
22/09/2019
Date of last data collection
Anticipated
29/11/2019
Actual
7/12/2019
Sample size
Target
140
Accrual to date
Final
149
Recruitment outside Australia
Country [1] 21239 0
New Zealand
State/province [1] 21239 0
Auckland

Funding & Sponsors
Funding source category [1] 301817 0
Other
Name [1] 301817 0
The Riddet Institute, Center of Research Excellence (CoRE)
Country [1] 301817 0
New Zealand
Primary sponsor type
University
Name
The University of Auckland Research Office
Address
Level 10, Building 620
49 Symonds St
Auckland 1010
New Zealand.
Country
New Zealand
Secondary sponsor category [1] 301561 0
None
Name [1] 301561 0
Address [1] 301561 0
Country [1] 301561 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 302521 0
Northern A Health and Disability Ethics Committee
Ethics committee address [1] 302521 0
Ethics committee country [1] 302521 0
New Zealand
Date submitted for ethics approval [1] 302521 0
13/11/2018
Approval date [1] 302521 0
18/12/2018
Ethics approval number [1] 302521 0
18/CEN/238

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 90502 0
Prof Sally Poppitt
Address 90502 0
Human Nutrition Unit
University of Auckland
18 Carrick Place
Mt Eden
Auckland 1024
New Zealand.
Country 90502 0
New Zealand
Phone 90502 0
+64 096305160
Fax 90502 0
Email 90502 0
[email protected]
Contact person for public queries
Name 90503 0
Jia Jiet Lim
Address 90503 0
Human Nutrition Unit
University of Auckland
18 Carrick Place
Mt Eden
Auckland 1024
New Zealand.
Country 90503 0
New Zealand
Phone 90503 0
+64 096301162
Fax 90503 0
Email 90503 0
[email protected]
Contact person for scientific queries
Name 90504 0
Jia Jiet Lim
Address 90504 0
Human Nutrition Unit
University of Auckland
18 Carrick Place
Mt Eden
Auckland 1024
New Zealand.
Country 90504 0
New Zealand
Phone 90504 0
+64 096301162
Fax 90504 0
Email 90504 0
[email protected]

Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
No
No/undecided IPD sharing reason/comment
This is in accordance to our ethical application that all data generated will only be used for this study only. However, if this is necessary, additional consent will be sought from the participants to allow the use of the data for other studies.


What supporting documents are/will be available?




Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
SourceTitleYear of PublicationDOI
EmbaseDoes a Higher Protein Diet Promote Satiety and Weight Loss Independent of Carbohydrate Content? An 8-Week Low-Energy Diet (LED) Intervention.2022https://dx.doi.org/10.3390/nu14030538
EmbaseNo Evidence That Circulating GLP-1 or PYY Are Associated with Increased Satiety during Low Energy Diet-Induced Weight Loss: Modelling Biomarkers of Appetite.2023https://dx.doi.org/10.3390/nu15102399
N.B. These documents automatically identified may not have been verified by the study sponsor.